Advanced search×

Insulin-like growth factors in the peripheral nervous system.

Kelli A KA Sullivan, Bhumsoo B Kim, and Eva L EL Feldman

Endocrinology 149(12):5963-71 (2008) PMID 18719018

IGF-I and -II are potent neuronal mitogens and survival factors. The actions of IGF-I and -II are mediated via the type I IGF receptor (IGF-IR) and IGF binding proteins regulate the bioavailability of the IGFs. Cell viability correlates with IGF-IR expression and intact IGF-I/IGF-IR signaling pathways, including activation of MAPK/phosphatidylinositol-3 kinase. The expression of IGF-I and -II, IGF-IR, and IGF binding proteins are developmentally regulated in the central and peripheral nervous system. IGF-I therapy demonstrates mixed therapeutic results in the treatment of peripheral nerve injury, neuropathy, and motor neuron diseases such as amyotrophic lateral sclerosis. In this review we discuss the role of IGFs during peripheral nervous system development and the IGF signaling system as the potential therapeutic target for the treatment of nerve injury and motor neuron diseases.

DOI: 10.1210/en.2008-1020
Version: za2963e q8za2 q8zb9 q8zcd q8zd9 q8ze2 q8zf0 q8zg4
Buy PDF

Similar articles you may find interesting…

  1. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diab...
    Hongyu H Zhang, Jharna J Saha, ... Frank C FC Brosius

    Am J Renal Physiol 295(4):F1071-81 (2008) PMID 18667486

    We confirm and extend these findings by showing that rosiglitazone treatment prevented the development of DN and reversed multiple markers of oxidative injury in DBA/2J mice made diabetic by low-dose streptozotocin. These diabetic mice developed a 14.2-fold increase in albuminuria and a 53% expansio...
    View PDF
  2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) meeting summary
    Timothy S Kern, Bruce A Berkowitz, and Eva L Feldman

    J Diabetes Complications 23(3):219-223 (2009) PMID 18413183

    The National Institute of Diabetes and Digestive and Kidney Diseases sponsored a meeting recently to explore new ways to assess diabetic retinopathy and neuropathy, both in diabetic patients and in diabetic mice. The workshop compared current gold standards for assessment of retinopathy and neuropat...
    Buy PDF
  3. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.
    Claudia C Figueroa-Romero, Mahdieh M Sadidi, and Eva L EL Feldman

    Rev Endocr Metab Disord 9(4):301-14 (2008) PMID 18709457

    We discuss the idea that excess glucose overloads the electron transport chain, leading to the production of superoxides and subsequent mitochondrial and cytosolic oxidative stress. Defects in metabolic and vascular pathways intersect with oxidative stress to produce the onset and progression of ner...
    Buy PDF